FTL (Ferritin Light Chain) is the light subunit of the ferritin heteropolymer, playing a crucial role in iron storage and homeostasis in the brain. Together with FTH1 (ferritin heavy chain), FTL forms the 24-subunit ferritin nanocage that sequesters excess iron and protects neurons from oxidative damage.
| FTL Protein |
|---|
| Gene | [FTL](/genes/ftl) |
| UniProt ID | [P02789](https://www.uniprot.org/uniprotkb/P02789) |
| PDB Structures | 2FFX, 3LYJ, 4Y0Y |
| Molecular Weight | ~20 kDa (subunit) |
| Subcellular Localization | Cytosol, nucleus |
| Protein Family | Ferritin family |
FTL is a 20 kDa subunit that co-assembles with FTH1 to form the native ferritin complex:
- Hydrophilic channels: Six 4-fold channels facilitate iron entry
- Hydrophobic core: Iron is stored as mineral ferric oxyhydroxide
- Co-assembly with FTH1: Ratio varies by tissue (typically 1:1 in brain)
- Long C-terminal helix: Unique to light chain, aids subunit interactions
The light chain has less ferroxidase activity but contributes to iron nucleation and long-term storage stability.
In the nervous system, FTL performs essential roles:
- Long-term Iron Storage: Provides stable iron reservoir in neurons and glia
- Oxidative Stress Mitigation: Prevents iron-catalyzed ROS formation
- Neuronal Iron Regulation: Modulates labile iron pool in dendrites and axons
- Glial Function: Supports astrocyte and oligodendrocyte iron metabolism
- Myelin Synthesis: Critical for oligodendrocyte iron requirements
FTL is expressed throughout the brain, with highest levels in the hippocampus, cortex, and basal ganglia.
- CSF biomarker: Elevated FTL in cerebrospinal fluid correlates with disease progression
- Amyloid interaction: Ferritin binds to amyloid-beta, potentially modulating plaque formation
- Iron dysregulation: Altered ferritin expression in AD brain regions
- Substantia nigra: Increased ferritin accumulation in dopaminergic neurons
- Neuromelanin complex: FTL associates with neuromelanin-iron complexes
- Levodopa response: Ferritin levels may influence treatment response
- FTL mutations: Autosomal dominant mutations cause neurodegeneration with brain iron accumulation (NBIA)
- Ferritin dysfunction: Impaired iron storage leads to free radical damage
- Basal ganglia pathology: Characteristic iron deposition in putamen and caudate
- Multiple Sclerosis: Altered ferritin in demyelinating lesions
- Friedreich's Ataxia: Compensatory FTL upregulation with frataxin deficiency
- Aging: Age-related iron accumulation correlates with cognitive decline
Therapeutic strategies targeting ferritin and iron metabolism:
| Agent |
Mechanism |
Development Stage |
| Iron chelators |
Reduce iron-mediated oxidative stress |
Clinical trials for PD/AD |
| Antioxidants |
Scavenge iron-generated ROS |
Preclinical |
| Ferritin modulators |
Alter ferritin expression/function |
Research |
- Fitzpatrick et al., Neuroferritinopathy (1999)
- Wang et al., CSF ferritin in AD (2020)
- Berg et al., Iron in Parkinson's disease substantia nigra (2001)
- Cai et al., Ferritin light chain in neurodegeneration (2018)
- Devos et al., Targeting iron in neurodegeneration (2022)